This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Company Filing History:
1 out of 834,307 Years Active: 2003
Title: David Kc Cooper: Innovator in Antibody-Mediated Xenograft Rejection
Introduction
David Kc Cooper is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of transplantation through his innovative research and patents. His work focuses on methods to improve the success of xenotransplantation by addressing the challenges posed by antibody-mediated rejection.
Latest Patents
David Kc Cooper holds a patent titled "Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients." This patent outlines a groundbreaking approach to mitigate antibody-mediated xenograft rejection. The methods involve either removing preformed antibodies to various identified carbohydrate xenoantigens from the recipient's circulation prior to transplantation or administering a xenoantibody-inhibiting amount of an identified xenoantigen shortly before graft revascularization.
Career Highlights
Throughout his career, David has focused on advancing the field of transplantation. His innovative methods have the potential to significantly improve the outcomes of xenotransplantation procedures. With 1 patent to his name, he has established himself as a key figure in this area of research.
Collaborations
David Kc Cooper has worked alongside talented individuals such as A Heather Good and Andrew J Malcolm. Their collaborative efforts have contributed to the advancement of knowledge and techniques in the field of transplantation.
Conclusion
David Kc Cooper's work in attenuating antibody-mediated xenograft rejection represents a significant advancement in transplantation science. His innovative methods and dedication to research continue to pave the way for future breakthroughs in this critical area.